StreetAlpha
13F holdings · Q3 2026

Jones Hill Capital

New York, NY · files as Jones Hill Capital LP
Know the moment Jones Hill Capital filesYou follow Jones Hill Capital An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 2102314

Jones Hill Capital reported 33 stocks worth $589M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are BMRN (11.9%), BCRX (10.0%) and TVTX (9.6%). Compared with Q2 2026, the fund opened new positions in BCRX, TVTX and INDV, added to PHVS, TRVI and BCAX, trimmed BMRN, INSM and IMCR and sold out of GILD, ARQT and MDGL.

Latest filing: what Jones Hill Capital did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
19 new9 added5 trimmed15 sold outBought about $393M · sold about $236M
New 19
See all 19 →
Added 9
See all 9 →
Trimmed 5
Sold out 15
See all 15 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$589M+25.3% vs last quarter
Stocks held3319 new · 15 sold out
Top 5 weight46.1%fairly concentrated
Turnover107%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 3 qtrsHeld
1
BMRN
Biomarin Pharmaceutical Inc
$70.3M11.9%1.2M−260K (−18%)3 of 3
2
BCRX
Biocryst Pharmaceuticals Inc
$59M10.0%7.1MNew position1 of 3
3
TVTX
Travere Therapeutics Inc
$56.5M9.6%960KNew position1 of 3
4
INDV
Indivior PLC
$54.7M9.3%1.5MNew position1 of 3
5
PHVS
Pharvaris N V
$31.3M5.3%988K+310K (+46%)3 of 3
6
CELC
Celcuity Inc
$30.4M5.2%383KNew position1 of 3
7
IONS
Ionis Pharmaceuticals Inc
$26.8M4.5%600KNew position1 of 3
8
SUPN
Supernus Pharmaceuticals Inc
$25.9M4.4%602KNew position1 of 3
9
NUVB
Nuvation Bio Inc
$25.1M4.3%4.5MNew position2 of 3
10
VERA
Vera Therapeutics Inc
$21.1M3.6%652KNew position1 of 3
🔒 23 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
GILD
Gilead Sciences Inc
$43.3M343K
ARQT
Arcutis Biotherapeutics Inc
$28.6M1.1M
MDGL
Madrigal Pharmaceuticals Inc
$28.2M53K
XENE
Xenon Pharmaceuticals Inc
$22.2M368K
ANIP
Ani Pharmaceuticals Inc
$19.4M234K

🔒 Free account: see all 15.

Reported value

last 3 quarters
$466MQ1 '26
$470MQ2 '26
$589MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Jones Hill Capital 13F FAQ

What does Jones Hill Capital own?

Jones Hill Capital reported 33 stocks worth $589M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are BMRN (11.9%), BCRX (10.0%) and TVTX (9.6%). The table above lists every position in the filing (the top 10 without an account).

What did Jones Hill Capital buy and sell in Q3 2026?

Compared with Q2 2026: 19 new positions, 9 added to, 5 trimmed and 15 sold out. New positions include BCRX, TVTX and INDV. It sold all of GILD, ARQT and MDGL.

When will Jones Hill Capital file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Jones Hill Capital's portfolio worth?

The Q3 2026 filing reports $589M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.